Presentation is loading. Please wait.

Presentation is loading. Please wait.

MarketsandMarkets Presents Genotyping Market worth $17.0 Billion by 2020 https://www.marketsandmarkets.com/Market-Reports/genotyping-market html.

Similar presentations


Presentation on theme: "MarketsandMarkets Presents Genotyping Market worth $17.0 Billion by 2020 https://www.marketsandmarkets.com/Market-Reports/genotyping-market html."— Presentation transcript:

1 MarketsandMarkets Presents Genotyping Market worth $17.0 Billion by 2020 https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html

2 The “Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), Products - Global Forecast to 2020” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.Genotyping Market Browse 113 market data tables and 37 figures spread through 200 pages and in- depth TOC on “Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), Products - Global Forecast to 2020" https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html

3 Early buyers will receive 10% customization on this report. https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html

4 https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html This report studies the global genotyping market with forecast to 2020. The global genotyping market is expected to reach $17.0 Billion in 2020 from $ 6.2 Billion in 2015, at a healthy CAGR of 22.3% from 2015 to 2020. Growth in this market is attributed to the increasing incidence of genetic diseases & increasing awareness about personalized medicine, technological advancements, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the increasing demand for genetic analysis in animal & plant livestock. However, the lack of appropriate reimbursement policies and a lack of technical know-how are curbing market growth to a certain extent.

5 https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html The global genotyping market is segmented by products & services, technology, applications, end users, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products & services, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents & kits, bioinformatics software and genotyping services. The reagents & kits market segment accounted for the largest share of 49% of the global genotyping market in 2014. The accessibility of a wide range of reagents and increasing need for genotyping for assessing drug efficacy and safety, to personalize the treatment for chronic diseases, to develop good breeds of animals & plants are some of the factors that are expected to drive the genotyping reagents market.

6 https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html North America, a major market for global genotyping, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. The Asia-Pacific market is expected to grow at a CAGR of 25.4% during the forecast period of 2015-2020. Countries like India, China, and Brazil will majorly drive market growth owing to the introduction of healthcare reforms, rising investments by public and private players to provide improved healthcare services in these countries, and the unmet medical needs of patients suffering from diseases such as cancer, diabetes and cardiovascular disease. Key players in this market include Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

7 https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html The genotyping market studied in this report is mainly segmented by product, technology, applications, and end user. The market, by product & services, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents and kits, bioinformatics software and services. Reagents & kits market is expected to grow at a CAGR of during the forecast period of 2015 to 2020. Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The market, by technology, is segmented into microarray, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, and others (allele specific oligonucleotide (ASO) probes, & in situ hybridization). Sequencing is the high growth market, owing to its widening application areas of DNA sequencing technologies, technological advancements, and the availability of high-speed sequencing instruments are expected to contribute to the growth of the DNA sequencing market in the coming years.

8 https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth of CAGR, 25.4% from 2015 to 2020, due to the huge demand for better healthcare services, expanding per capita income, increasing ongoing clinical trials in these regions, and the increasing focus of leading players on these regions. The key players operating in genotyping market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.).

9 Contact Us Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.comsales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html

10 About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. https://www.marketsandmarkets.com/Market-Reports/genotyping-market- 249958595.html


Download ppt "MarketsandMarkets Presents Genotyping Market worth $17.0 Billion by 2020 https://www.marketsandmarkets.com/Market-Reports/genotyping-market html."

Similar presentations


Ads by Google